InfuSystems Holdings Inc (INFU) - Total Liabilities
Based on the latest financial reports, InfuSystems Holdings Inc (INFU) has total liabilities worth $39.91 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of InfuSystems Holdings Inc to track the company's year-over-year net asset growth rate.
InfuSystems Holdings Inc - Total Liabilities Trend (2005–2025)
This chart illustrates how InfuSystems Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See INFU FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
InfuSystems Holdings Inc Competitors by Total Liabilities
The table below lists competitors of InfuSystems Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vestland Berhad
KLSE:0273
|
Malaysia | RM693.96 Million |
|
Chia Chang Co Ltd
TW:4942
|
Taiwan | NT$2.30 Billion |
|
Black Spade Acquisition II Co Unit
NASDAQ:BSIIU
|
USA | $6.81 Million |
|
Reit Azorim HF Living Ltd
TA:AZRT
|
Israel | ILA2.19 Billion |
|
Draganfly Inc
NASDAQ:DPRO
|
USA | $5.37 Million |
|
CAMP4 THERAPEUTICS CORPORATION
NASDAQ:CAMP
|
USA | $74.56 Million |
|
Aimia Inc
TO:AIM
|
Canada | CA$540.70 Million |
|
La Finca Global Assets SOCIMI S.A.
MC:YLFG
|
Spain | €521.85 Million |
Liability Composition Analysis (2005–2025)
This chart breaks down InfuSystems Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see InfuSystems Holdings Inc (INFU) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how InfuSystems Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for InfuSystems Holdings Inc (2005–2025)
The table below shows the annual total liabilities of InfuSystems Holdings Inc from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $43.23 Million | -6.19% |
| 2024-12-31 | $46.09 Million | -8.95% |
| 2023-12-31 | $50.61 Million | -1.50% |
| 2022-12-31 | $51.38 Million | +4.20% |
| 2021-12-31 | $49.31 Million | -12.31% |
| 2020-12-31 | $56.24 Million | -1.14% |
| 2019-12-31 | $56.89 Million | +30.39% |
| 2018-12-31 | $43.63 Million | +15.04% |
| 2017-12-31 | $37.93 Million | -16.92% |
| 2016-12-31 | $45.66 Million | +1.07% |
| 2015-12-31 | $45.17 Million | +33.80% |
| 2014-12-31 | $33.76 Million | -2.57% |
| 2013-12-31 | $34.65 Million | -7.62% |
| 2012-12-31 | $37.51 Million | +3.91% |
| 2011-12-31 | $36.10 Million | -20.17% |
| 2010-12-31 | $45.22 Million | +36.11% |
| 2009-12-31 | $33.23 Million | -8.08% |
| 2008-12-31 | $36.15 Million | -24.17% |
| 2007-12-31 | $47.67 Million | +35.60% |
| 2006-12-31 | $35.15 Million | +19532.09% |
| 2005-12-31 | $179.05K | -- |
About InfuSystems Holdings Inc
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment … Read more